| Pharmaceutical active ingredients: |
| Phenylephrine HydrochlorideSulfacetamide Sodium |
| Available forms, composition and doses of Vasosulf: |
| Drops; Ophthalmic; Phenylephrine Hydrochloride 1.25 mg; Sulfacetamide Sodium 150 mg / ml |
| Vasosulf medical category: |
| Human:Vasoconstrictors |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| S01AB54 - Sulfacetamide, combinationsS01GA55 - Phenylephrine, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| NovartisIolab Pharmaceuticals |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Vita 3 | Phenylephrine Hydrochloride; Rutin Sodium Sulfate | Novartis |
| Murocoll-2 | Phenylephrine Hydrochloride; Scopolamine Hydrobromide | Bausch and Lomb |
| Rectacaine Ointment | Phenylephrine Hydrochloride; Shark Liver Oil | Reese Pharmaceutical |
| Relief | Phenylephrine Hydrochloride; Shark Liver Oil | Sagmel; Instituto de Angeli |
| Sperti Plus Preparacion H | Phenylephrine Hydrochloride; Shark Liver Oil | Wyeth |
| KGS-PE | Phenylephrine Hydrochloride; Sulfogaiacol | Cypress Pharmaceutical |
| Oculoforte | Phenylephrine Hydrochloride; Tetrahydrozoline Hydrochloride; Zinc Sulfate | Novartis |
| Hayphryn | Phenylephrine Hydrochloride; Thenyldiamine Hydrochloride | Sanofi-Aventis |
| Neo-Synephrine Nasal Spray | Phenylephrine Hydrochloride; Thenyldiamine Hydrochloride | Bayer Schering Pharma; GlaxoSmithKline |
| NTR | Phenylephrine Hydrochloride; Thenyldiamine Hydrochloride | Teofarma |